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INTRODUCTION
Cow’s milk allergy (CMA) is one of the most common ad-
verse reactions to foods in infancy and early childhood. It mani-
fests various symptoms in the skin (atopic dermatitis, urticaria,
and angioedema), gastrointestinal tract (vomiting, diarrhea,
colics, and gastroesophageal reflux), or respiratory tract (rhini-
tis, wheezing, dyspnea, and cough). Treatment of CMA is ba-
sed on the elimination of cow’s milk protein from the diet.
For this purpose hypoallergic formula or soy protein-based
formula has been used in infants with CMA (1, 2).
Soy protein formula is similar to cow’s milk protein in the
distribution of nutrients, and thus provides normal growth
and immunologic status (3, 4). It has been widely used espe-
cially for infants with CMA as a substitute, because of its low
allergenicity (5), low cost, good palatability, nutritional adequa-
cy, and no cross reactivity to cow’s milk protein. However, soy
protein formula has been in limited use, because some of the
CMA patients are allergic to soy protein as well (6-13).
Soy-based foods are popular in Korea, and thus Korean in-
fants and children have been frequently fed with soy-contain-
ing foods, such as soymilk, soybean curd (tofu), soy-based
soup, soy sauce, and so on. In particular, soy protein formula
has been commonly used for either normal healthy infants or
those who are allergic to cow’s milk protein. Based on the
concept that food allergy is given rise to by various factors
including the nature of allergen, dose and frequency of anti-
gen exposure, etc. (14), the prevalence of food allergy to vari-
ous offending allergens partly depends on the regional differ-
ences of dietary habits during infancy. For that reason, one can
speculate that soy protein formula is not an appropriate diet
for CMA patients in some areas where soy protein allergy is
highly prevalent.
In this study, we evaluated the prevalence of soy protein
hypersensitivity in cow’s milk protein-sensitive children in
Korea, where children are exposed to soy-based food from a
very young age.
MATERIALS AND METHODS
Study population
A total of 1,363 children and adolescents referred to the
Allergy Clinic of Samsung Medical Center for atopic disease
were enrolled in this study. Atopic disease included atopic der-
matitis, urticaria, enterocolitis syndrome, bronchial asthma,
and allergic rhinitis. IgE- and non-IgE-associated soy protein
hypersensitivity was evaluated to determine the prevalence of
soy allergy in cow’s milk-sensitive children.
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Prevalence of Soy Protein Hypersensitivity in Cow’ s Milk Protein-
Sensitive Children in Korea
This study was aimed to evaluate the prevalence of soy protein hypersensitivity in
cow’s milk protein-sensitive children in Korea. A total of 1,363 patients with atopic
dermatitis, urticaria, enterocolitis syndrome, bronchial asthma or allergic rhinitis
were recruited. First, we estimated the prevalence of sensitization to soy in children
sensitized to cow’s milk. Specific IgE levels > 0.7 kU/L by CAP assay were consid-
ered positive. Next, the prevalence of soy allergy in cow’s milk allergy (CMA) pati-
ents was investigated. Those children whose parents agreed to participate the open
challenge test with soy had a convincing history of allergic reactions elicited by
cow’s milk and these symptoms were relieved by elimination. All of them had neg-
ative soy-specific IgE. Patients with positive soy-specific IgE accounted for 18.3%
of 224 children sensitized to cow’s milk protein. The prevalence of sensitization to
soy decreased with age (36.8% in the first year of life, 16.4% in the second year,
and 13.7% in the third year). Of 21 CMA patients, 42.9% (n=9) were determined to
have soy allergy (mean age 10.3 months). Our results suggest that soy protein
formula should be carefully used as a substitute for cow’s milk in CMA patients,
especially during infancy.
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First, the prevalence of IgE-associated soy hypersensitivity
in cow’s milk-sensitive atopic patients was evaluated. The pres-
ence of specific IgE against both cow’s milk and soy was check-
ed by either the Pharmacia CAP assay (Pharmacia and Upjohn,
Uppsala, Sweden) or skin prick test. Those who performed
CAP assay had atopic dermatitis, urticaria or enterocolitis sym-
drome, while skin prick test was done in children over the age
of 5 yr with bronchial asthma or allergic rhinitis, either alone
or in combination. Of 1,363 patients, 224 children with pos-
itive cow’s milk-specific IgE were investigated to determine
whether they were sensitized to soy protein as well. The preva-
lence according to the age was also analyzed. The mean age of
these patients sensitized to cow’s milk protein was 2.5 yr (range
3-141 months).
Next, the prevalence of non-IgE-associated soy hypersensi-
tivity in cow’s milk-sensitive children was evaluated. Of 1,363
patients, children with a convincing history of allergic reaction
elicited by cow’s milk were recruited. Among these patients
with convincing history, 21 children were diagnosed as having
cow’s milk allergy (CMA) by relief of clinical symptoms with
elimination of cow’s milk protein from the diet. These patients
had atopic dermatitis (n=13), urticaria (n=5), or enterocolitis
syndrome (n=3), and no patients had a history of anaphylaxis
by cow’s milk ingestion. Nine patients showed positive cow’s
milk-specific IgE, while 12 of them did not. After the inform-
ed consent was obtained from their parents, open food chal-
lenge test was performed with soy. All of the patients had neg-
ative CAP value of soy-specific IgE. The serum total IgE level
was 59.2 kU/L on average (range 3.3-270 kU/L), and the mean
age was 12.8 months (range 2-35 months).
Serum specific IgE
Sera from children with atopic disease were analysed for spe-
cific IgE antibodies to cow’s milk and soy by the CAP system
(Pharmacia-Upjohn) according to the manufacturer’s instruc-
tions. Briefly, patients’ sera were obtained at their first visit.
Fifty microliters of sera were added to Immuno CAP and incu-
bated for 30 min. After washing, 50  L of enzyme-anti-IgE
were added. After incubation for 150 min, each sample was
washed, and 50  L of development solution was added. Incu-
bation for 10 min was followed by the addition of stop solu-
tion. Fluorescent eluate from Immuno CAP was measured in
FluoroCount 96 and was determined by comparing with the
values from the standard curve. Concentrations above 0.7 kU/
L were regarded as positive. The level of specific IgE was ex-
pressed as mean±standard deviation (SD).
Skin prick test
Skin prick test was performed with cow’s milk and soy (To-
rii, Japan). Briefly, allergen extracts were applied by means of
the prick technique. Histamine and saline were used as positive
and negative control, respectively. Skin prick test results were
considered positive when the wheal size elicited by food aller-
gens was equal to or greater than that produced by the positive
control.
Food challenges
Food challenge test was performed in CMA patients with
no specific IgE antibody to soy protein. They were fed with soy
protein formula for 2 weeks with 2.1 g of protein/kg of body
weight/day. In those who manifested aggravating symptoms
(eczema, urticaria, diarrhea) from soy protein formula, an exten-
sively hydrolyzed formula (HA
�, Maeil, Korea) was given for
2 weeks to eliminate soy protein from their diet. Their symp-
toms were monitored by a physician at the Allergy Clinic. They
were also fed with weaning diet except allergenic foods such
as egg, soy, wheat, and peanut. During the study period, no
additional weaning diet was offered. Diagnosis of soy allergy
was established when the soy protein formula elicited atopic
symptoms which were relieved by subsequent elimination.
Statistics
Statistical analysis was performed using SPSS 10.0 pro-
gram. The Fisher’s exact test and Mann-Whitney test were
used to compare data from patients with positive soy chal-
lenges and those with negative soy challenges. A p value
<0.05 was considered significant.
RESULTS
Prevalence of soy protein sensitization in atopic
patients sensitized to cow’s milk protein
Two hundred and twenty four (16.4%) of 1,363 patients
CM(-), Soy(+)  
Fig. 1. Prevalence of soy protein sensitization in children who were
sensitized to cow’s milk protein. The mean age of patients sensitized
to both cow’s milk (CM) and soy protein was 2.5 yr. Most of them (n=
34) had atopic dermatitis. Prevalence was written in the parentheses.
n=33
n=41
(18.3 %)
n=183
CM (-), Soy (+)
CM (+), Soy (+)
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with atopic disease were sensitized to cow’s milk protein, while
74 (5.4%) of them were sensitized to soy protein. Among 224
atopic children who were sensitized to cow’s milk protein, 41
patients were sensitized to soy protein as well (Fig. 1). The
prevalence was 18.3% (95% CI=13.2-23.4%). The male-to-
female ratio was 30:11, and most of them (n=34) had atopic
dermatitis. The level of specific IgE against cow’s milk protein
was 15.9±29.0 kU/L (range 0.89-101 kU/L), and that against
soy protein was 12.4±20.6 kU/L (range 0.83-101 kU/L).
The prevalence of soy protein sensitization in cow’s milk-
sensitive children was analysed by age. As shown in Fig. 2, the
prevalence of soy protein sensitization in infants less than one
year who were sensitized to cow’s milk protein was 36.8%,
and it was shown to decrease with age. The prevalences during
the second, third, and fourth year of their lives were 16.4%,
13.7%, and 9.4%, respectively.
Prevalence of non-IgE-associated soy hypersensitivi-
ty in cow’s milk allergy patients
Children with CMA, established by a convincing history and
elimination, were challenged with soy protein formula. Their
CAP values of soy-specific IgE were negative. Among 21 chil-
dren with CMA, 9 were allergic to soy protein as well, while
12 were not (Table 1); 5/9 patients had atopic dermatitis, 3/9
had enterocolitis syndrome, and 1/9 had urticaria. The preva-
lence of non-IgE-associated soy protein hypersensitivity in
CMA patients was 42.9% (95% CI = 21.7-64.1%). The mean
ages of the positive and negative response groups to soy chal-
lenge were 10.3 and 13.3 months, respectively. However, there
was no statistically significant difference between the two gro-
ups in terms of sex, age, diagnosis, total IgE, and specific IgE
against cow’s milk protein (p>0.05).
DISCUSSION
Food allergy is an adverse reaction after ingestion of food,
which is caused by either IgE-mediated or non-IgE-mediated
immune mechanism. In food allergy patients skin prick tests
for foods and tests for detecting circulating specific IgE anti-
bodies against food allergen have a good negative predictive
value but a rather poor positive predictive value (15). This is
because in some children specific IgE to foods may occur as a
transient phenomenon regardless of the presence of atopy (16).
For the diagnosis of food allergy, double-blind, placebo-con-
trolled, food challenge test (DBPCFC) is considered as the
gold standard method. Ideally DBPCFC should be used for
the evaluation of either IgE- or non-IgE-mediated food allergy.
However, DBPCFC is time-consuming and complicated. Be-
sides it sometimes triggers severe adverse reaction such as ana-
phylaxis and thus some parents refuse to perform challenge test
to their children, especially when the patients are infants. There-
fore DBPCFC is difficult to perform in clinical practice for
the diagnosis of food allergy.
Recently in the pediatric population quantification of food-
specific IgE was reported to be useful for diagnosing IgE-asso-
ciated symptomatic allergy to egg, milk, peanut, and fish ins-
tead of DBPCFC (17). In that report, diagnostic decision po-
ints that are 90% to 100% predictive of clinical reactivity to
each allergen was established. For the patients with food-specif-
ic IgE below the decision points DBPCFC is required to con-
firm the diagnosis. When only the patients with specific IgE
above the decision point were studied without DBPCFC, the
prevalence of food allergy to each allergen would be underesti-
mated. On the other hand, the prevalence of sensitization mi-
ght be higher than that of food allergy confirmed by DBPCFC.
Nevertheless we estimated the prevalence of sensitization for
the IgE-mediated hypersensitivity in the symptomatic atopic
children, based on the fact that sensitization to food allergen
is often the first evidence of development of IgE-mediated ato-
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Fig. 2. Prevalences of soy protein sensitization in children who were
sensitized to cow’s milk protein according to the age. Prevalence
in each age group is written above each bar. CM, cow’s milk.
16.4 %
13.7 %
9.4 %
16.7 %
Number of patients (%) 9 (42.9%) 12 (57.1%)
Sex ratio (male/female) 6/3 5/7 0.387
Mean age (months) 10.3 13.3 0.651
Total IgE (kU/L) 42.0 72.1 0.554
Cow’s milk protein-specific 0.51±0.66* 0.96±1.32* 0.651
IgE (kU/L)
Soy protein-specific IgE (kU/L) 0 0
Diagnosis 0.136
Atopic dermatitis 5 8
Urticaria 1 4
Enterocolitis 3 0
Challenge test
with soy (+)
p value
Challenge test
with soy (-)
Table 1. Clinical data of patients with cow’s milk allergy who per-
formed the open food challenge test with soy
* mean±standard deviation.476 K.-M. Ahn, Y.-S. Han, S.-Y. Nam, et al.
pic disease in genetically predisposed subjects. In the present
study the prevalence of sensitization to soy protein in atopic
children was observed as 5.4%. This figure is similar to those
reported from previous studies (18-21), which varied from 4%
to 22%. This variability is probably due to the differences in
methodology to identify specific IgE to soy protein, either in
vitro or in vivo and in patient selection such as disease entity,
age distribution, specialty referral, involved area with different
dietary habits, etc. The prevalence of sensitization to cow’s milk
protein in our study was 16.4%, and among them 18.3% of
children was sensitized to soy protein as well. In particular, the
prevalence of soy protein sensitization in patients sensitized
to cow’s milk protein during infancy was as high as 36.8%,
suggesting that this period is critical in sensitization to food
allergen.
For diagnosing non-IgE-mediated soy allergy open challen-
ge test was undertaken only in selected children whose parents
agreed to participate. All of them are symptomatic CMA pati-
ents and showed negative soy-specific IgE. They were challen-
ged with soy protein formula on the basis of the report that
both skin prick test and RAST have a good negative predictive
value (22). Our data showed that the prevalence of non-IgE-
associated soy protein allergy in CMA children was 42.9%.
Bock et al. reported that only 6.9% of the children with CMA
showed soy protein allergy, which was evidenced by either
DBPCFC or open challenge test (6). Of a 93 IgE-associated
CMA cohort (age range 3 to 41 months), 14% were deter-
mined to have soy allergy according to Zeiger et al. (7). On
the contrary, some authors demonstrated a higher prevalence
of soy allergy in CMA patients, varying from 30% to 100%
(8-13). This difference is related to the number of study pop-
ulation, patients’ age, diagnostic method, and so on. In other
words, those studies involved a small number of patients, a
young age group of less than 12 months, and history-based
diagnosis of soy allergy demonstrated a high prevalence, while
IgE-associated CMA children were likely to demonstrate a
low prevalence. In the present study, the small size of study
population (n=21) and mixed type of CMA children might
have influenced the 42.9% prevalence of soy allergy. In addi-
tion, soy allergy was diagnosed by open food challenge test,
although ideally negative responses to open food challenge
should be confirmed by DBPCFC. The mechanism of non-
IgE-mediated food allergy still remains unclear, although food
antigen-specific IgG might be involved. These antigen-spe-
cific IgG (IgG4) antibodies are known to reflect the type of
foods ingested and not indicative of specific food-related patho-
genesis (23). In the present study the role of food-specific IgG
was not evaluated.
Treatment of food allergy is to avoid offending food aller-
gens. In 1983, the Committee on Nutrition of the American
Academy of Pediatrics recommended that soy protein formula
should not be used in the dietary management of documented
clinical allergic reactions to cow’s milk protein (24). However,
Businco et al. (25) claimed that no references were provided
showing that protein hydrolyzed formulas are superior to soy
protein formula in children with CMA. Zeiger et al. (7) sugge-
sted that soy protein formula is generally a safe formula for
IgE-associated CMA children, which was consistent with the
recommendations of the same committee in 1998 (1). Recent-
ly, 30 kDa of a soy protein component was identified as a mole-
cule to cross-react with caseins from cow’s milk (26). This resu-
lt suggests that in vitro cross-reactivity should be considered
when CMA patients are treated with soy-derivatives. Contro-
versies still remain whether soy protein formula can be used
as a preferred alternative in CMA children, especially during
infancy.
In conclusion, the prevalence of sensitization to soy protein
in Korean atopic children sensitized to cow’s milk protein was
estimated at 18.3%, while the prevalence of non-IgE-asso-
ciated soy allergy in CMA children was revealed to be 42.9%.
DBPCFC studies in larger cohorts of babies may provide more
reliable data on the prevalence of soy allergy in Korea. Our
results suggest that soy protein-based formula should be care-
fully used as a substitute for cow’s milk in CMA patients, espe-
cially in the first year of life.
REFERENCES
1. American Academy of Pediatrics. Committee on nutrition. Soy pro-
tein-based formulas: Recommendations for use in infant feeding. Pedi-
atrics 1998; 101: 148-53.
2. American Academy of Pediatrics. Committee on nutrition. Hypoal-
lergenic infant formulas. Pediatrics 2000; 106: 346-9.
3. Businco L, Bruno G, Grandolfo ME, Novello F, Fiore L, Amato C.
Response to poliovirus immunization and type of feeding in babies of
atopic families. Pediatr Allergy Immunol 1990; 1: 60-3.
4. Zoppi G, Gasparini R, Mantovanelli F, Gobio-Casali L, Astolfi R,
Crovari P. Diet and antibody response to vaccinations in healthy in-
fants. Lancet 1983; 2: 11-4.
5. Eastham EJ, Lichauco T, Pang K, Walker WA. Antigenicity of infant
formulas and the induction of systemic immunological tolerance by
oral feeding: cow’s milk versus soy milk. J Pediatr Gastroenterol Nutr
1982; 1: 23-8.
6. Bock SA, Atkins FM. Patterns of food hypersensitivity during sixteen
years of double-blind, placebo-controlled food challenges. J Pediatr
1990; 117: 561-7.
7. Zeiger RS, Sampson HA, Bock SA, Burks AW Jr, Harden K, Noone
S, Martin D, Leung S, Wilson G. Soy allergy in infants and children
with IgE-associated cow’s milk allergy. J Pediatr 1999; 134: 614-22.
8. Jakobsson I, Lindberg T. A prospective study of cow’s milk protein
intolerance in Swedish infants. Acta Paediatr Scand 1979; 68: 853-9.
9. Burks AW, Casteel HB, Fiedorek SC, Williams LW, Pumphrey CL.
Prospective oral food challenge study of two soybean isolates in pati-
ents with possible milk or soy protein enterocolitis. Pediatr Allergy
Immunol 1994; 5: 40-5.
10. Van Sickle GJ, Powell GK, McDonald PJ, Goldblum RM. Milk- and
soy protein-induced enterocolitis: evidence for lymphocyte sensitiza-tion to specific food proteins. Gastroenterology 1985; 88: 1915-21.
11. Bishop JM, Hill DJ, Hosking CS. Natural history of cow’s milk aller-
gy: clinical outcome. J Pediatr 1990; 116: 862-7.
12. Paganus A, Juntrunen-Backman K, Savilahti E. Follow-up of nutri-
tional status and dietary survey in children with cow’s milk allergy.
Acta Paediatr 1992; 81: 518-21.
13. Hill DJ, Ford RP, Shelton MJ, Hosking CS. A study of 100 infants and
young children with cow’s milk allergy. Clin Rev Allergy 1984; 2:
125-42.
14. Sampson HA. Food allergy. Part 1: Immunopathogenesis and clini-
cal disorders. J Allergy Clin Immunol 1999; 103: 717-28.
15. Bock SA, Sampson HA, Atkins FM, Zeiger RS, Lehrer S, Sachs M,
Bush RK, Metcalfe DD. Double-blind, placebo-controlled food chal-
lenge (DBPCFC) as an office procedure: a manual. J Allergy Clin
Immunol 1988; 82: 986-97.
16. Hattenvig G, Kjellman B, Bjorksten B. Appearance of IgE antibodies
to ingested and inhaled allergens during the first 12 yr of life in atopic
and nonatopic children. Pediatr Allergy Immunol 1993; 4: 182-6.
17. Sampson HA. Utility of food-specific IgE concentrations in predicting
symptomatic food allergy. J Allergy Clin Immunol 2001; 107: 891-6.
18. Sampson HA. The role of food hypersensitivity and mediator release
in atopic dermatitis. J Allergy Clin Immunol 1988; 81: 635-45.
19. Bruno G, Giampietro PG, Del Guercio MJ, Gallia P, Giovannini L,
Lovati C, Paolucci P, Quaglio L, Zoratto E, Businco L. Soy allergy
is not common in atopic children: a multicenter study. Pediatr Allergy
Immunol 1997; 8: 190-3.
20. Magnolfi CF, Zani G, Lacava L, Patria MF, Bardare M. Soy allergy
in atopic children. Ann Allergy Asthma Immunol 1996; 77: 197-201.
21. Giampietro PG, Ragno W, Daniele S, Cantani A, Ferrara M, Businco
L. Soy hypersensitivity in children with food allergy. Ann Allergy 1992;
69: 143-6.
22. Cantani A. Diagnostic criteria for food allergy with predominantly
intestinal symptoms. J Pediatr Gastroenterol Nutr 1993; 16: 476-8.
23. Sampson HA. Food allergy. Part 2: Diagnosis and management. J
Allergy Clin Immunol 1999; 103: 981-9.
24. Committee on nutrition. Soy-protein formulas: Recommendations for
use in infant feeding. Pediatrics 1983; 72: 359-63.
25. Businco L, Bruno G, Giampietro PG. Soy protein for the prevention
and treatment of children with cow-milk allergy. Am J Clin Nutr 1998;
68 (Suppl): S1447-52.
26. Rozenfeld P, Docena GH, Anon MC, Fossati CA. Detection and iden-
tification of a soy protein component that cross-reacts with caseins
from cow’s milk. Clin Exp Immunol 2002; 130: 49-58.
Soy Protein Hypersensitivity with Cow’s Milk Allergy 477